A U.S. Phase III Trial to Compare HX575 (Proposed Biosimilar Epoetin Alfa) with Epogen®/ Procrit® in Renal Anemia Patients

Authors

Nelson Kopyt DO, FASN, FACP, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

11-2016

Published In/Presented At

https://www.asn-online.org/abstracts/

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article